164 related articles for article (PubMed ID: 23189378)
1. Benfluorex: lesions on a bioprosthetic heart valve too.
Prescrire Int; 2012 Oct; 21(131):240-1. PubMed ID: 23189378
[No Abstract] [Full Text] [Related]
2. Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus.
Weill A; Païta M; Tuppin P; Fagot JP; Neumann A; Simon D; Ricordeau P; Montastruc JL; Allemand H
Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1256-62. PubMed ID: 20945504
[TBL] [Abstract][Full Text] [Related]
3. eComment: Factors related to bioprosthetic valve calcification in the elderly.
Gunay R; Bicer M; Sensoz Y; Demirtas MM
Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):846. PubMed ID: 19828657
[No Abstract] [Full Text] [Related]
4. Unexpected long durability of a low-profile porcine Liotta bioprosthesis in mitral position.
Campanella A; Comoglio C; Sansone F; Rinaldi M
J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):492-3. PubMed ID: 19346969
[TBL] [Abstract][Full Text] [Related]
5. Early stenosis of Medtronic Mosaic bioprosthesis in the aortic position.
Peeceeyen S; Cao C; Fermanis G; Manganas C
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):e13-4. PubMed ID: 22104666
[No Abstract] [Full Text] [Related]
6. Mitral bioprosthesis hypertrophic scaring and native aortic valve fibrosis during benfluorex therapy.
Ayme-Dietrich E; Lawson R; Gasser B; Dallemand R; Bischoff N; Monassier L
Fundam Clin Pharmacol; 2012 Apr; 26(2):215-8. PubMed ID: 22320434
[TBL] [Abstract][Full Text] [Related]
7. How can benfluorex-related heart valve disease be identified by echocardiography?
Tribouilloy C; Rusinaru D; Andréjak M
Arch Cardiovasc Dis; 2011 Oct; 104(10):489-92. PubMed ID: 22044700
[No Abstract] [Full Text] [Related]
8. Operative finding of aortic cusp prolapse in benfluorex-induced aortic regurgitation.
Ennezat PV; Bruneval P; Maréchaux S; Bellemin JP; Senellart F; Arnaud-Crozat E; Ramadan R; Obadia JF; Touati G; Fleury JP; Tribouilloy C
Int J Cardiol; 2015; 186():231-2. PubMed ID: 25828122
[No Abstract] [Full Text] [Related]
9. Seven-year outcome of pulmonary valve autograft replacement of the mitral valve in an infant.
Kanzaki T; Yamagishi M; Yashima M; Yaku H
J Thorac Cardiovasc Surg; 2011 May; 141(5):e33-5. PubMed ID: 21377700
[No Abstract] [Full Text] [Related]
10. Bioprosthetic mitral valve dysfunction due to native valve preserving procedure.
Matsuno Y; Mori Y; Umeda Y; Takiya H
Asian Cardiovasc Thorac Ann; 2016 Mar; 24(3):276-9. PubMed ID: 25392048
[TBL] [Abstract][Full Text] [Related]
11. [Valvular regurgitation caused by anorectic agents].
Melero Tejedor JM; Rodríguez Bailón I; Such Martínez M; Porras Martín C; Olalla Mercadé E; Espinosa Caliani JS
Rev Esp Cardiol; 2000 Dec; 53(12):1667-70. PubMed ID: 11171493
[TBL] [Abstract][Full Text] [Related]
12. St Jude Medical Epic porcine bioprosthesis: results of the regulatory evaluation.
Jamieson WR; Lewis CT; Sakwa MP; Cooley DA; Kshettry VR; Jones KW; David TE; Sullivan JA; Fradet GJ; Bach DS
J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1449-54.e2. PubMed ID: 21277603
[TBL] [Abstract][Full Text] [Related]
13. Frequency of drug-induced valvular heart disease in patients previously exposd to benfluorex: a multicentre prospective study.
Tribouilloy C; Maréchaux S; Jobic Y; Jeu A; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Garban T; Ennezat PV; Andréjak M; Rusinaru D
Eur Heart J; 2013 Dec; 34(46):3580-7. PubMed ID: 24014218
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of left heart valve regurgitation associated with benfluorex use in patients with diabetes mellitus: a multicenter study.
Tribouilloy C; Rusinaru D; Maréchaux S; Jeu A; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Ennezat PV; Garban T; Jobic Y
Circulation; 2012 Dec; 126(24):2852-8. PubMed ID: 23143159
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced valve disease and considerations of benefit versus risk.
Borer JS
Eur Heart J; 2013 Dec; 34(46):3535-7. PubMed ID: 24042062
[No Abstract] [Full Text] [Related]
16. Bioprosthetic durability assessment: importance of complete data.
Jamieson WR
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):596; author reply 596-7. PubMed ID: 21241868
[No Abstract] [Full Text] [Related]
17. Transcatheter valve-in-valve implantation with the Edwards SAPIEN in patients with bioprosthetic heart valve failure: the Milan experience.
Latib A; Ielasi A; Montorfano M; Maisano F; Chieffo A; Cioni M; Mussardo M; Bertoldi L; Shannon J; Sacco F; Covello RD; Figini F; Godino C; Grimaldi A; Spagnolo P; Alfieri O; Colombo A
EuroIntervention; 2012 Mar; 7(11):1275-84. PubMed ID: 22278193
[TBL] [Abstract][Full Text] [Related]
18. Prosthesis-patient mismatch in the mitral position: old concept, new evidences.
Pibarot P; Dumesnil JG
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1405-8. PubMed ID: 17532928
[No Abstract] [Full Text] [Related]
19. Impact of selective serotonin reuptake inhibitor therapy on heart valves in patients exposed to benfluorex: a multicentre study.
Maréchaux S; Jeu A; Jobic Y; Ederhy S; Donal E; Réant P; Abouth S; Arnasteen E; Boulanger J; Ennezat PV; Garban T; Szymanski C; Tribouilloy C
Arch Cardiovasc Dis; 2013; 106(6-7):349-56. PubMed ID: 23876809
[TBL] [Abstract][Full Text] [Related]
20. [About the settlement of litigations concerning the harm caused by benfluorex (Mediator®)].
Nicot P; Frachon I; Hill C
Presse Med; 2013 Apr; 42(4 Pt 1):411-8. PubMed ID: 23490638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
